Sunesis Pharmaceuticals Inc. (SNSS)

0.55
0.02 3.60
NASDAQ : Health Technology
Prev Close 0.57
Open 0.57
Day Low/High 0.51 / 0.58
52 Wk Low/High 0.20 / 1.83
Volume 425.69K
Avg Volume 470.40K
Exchange NASDAQ
Shares Outstanding 111.32M
Market Cap 63.45M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Sunesis Pharmaceuticals To Present At The Wells Fargo Healthcare Conference

Sunesis Pharmaceuticals To Present At The Wells Fargo Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Aug.

Sunesis Pharmaceuticals Reports Second Quarter 2019 Financial Results And Recent Highlights

Sunesis Pharmaceuticals Reports Second Quarter 2019 Financial Results And Recent Highlights

Sunesis to Host Conference Call Today at 4:30 PM Eastern Time

Sunesis Pharmaceuticals To Host Conference Call On August 7th To Discuss Second Quarter 2019 Financial Results And Recent Highlights

Sunesis Pharmaceuticals To Host Conference Call On August 7th To Discuss Second Quarter 2019 Financial Results And Recent Highlights

SOUTH SAN FRANCISCO, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc.

Sunesis Announces Pricing Of $25 Million Offering Of Securities

Sunesis Announces Pricing Of $25 Million Offering Of Securities

SOUTH SAN FRANCISCO, Calif., July 10, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc.

Sunesis Announces Proposed Public Offering Of Common Stock And Preferred Stock

Sunesis Announces Proposed Public Offering Of Common Stock And Preferred Stock

SOUTH SAN FRANCISCO, Calif., July 10, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Announces Executive Promotions And Provides Clinical Update

Sunesis Pharmaceuticals Announces Executive Promotions And Provides Clinical Update

300 mg Cohort of Phase 1b/2 Trial of Vecabrutinib now Enrolling

First Week Of June 21st Options Trading For Sunesis Pharmaceuticals (SNSS)

First Week Of June 21st Options Trading For Sunesis Pharmaceuticals (SNSS)

Investors in Sunesis Pharmaceuticals Inc saw new options become available this week, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SNSS options chain for the new June 21st contracts and identified one put and one call contract of particular interest.

Sunesis Pharmaceuticals Reaches Analyst Target Price

Sunesis Pharmaceuticals Reaches Analyst Target Price

In recent trading, shares of Sunesis Pharmaceuticals Inc have crossed above the average analyst 12-month target price of $6.00, changing hands for $6.02/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Sunesis Pharmaceuticals Reports Third Quarter 2017 Financial Results And Recent Highlights

Sunesis Pharmaceuticals Reports Third Quarter 2017 Financial Results And Recent Highlights

Sunesis to Host Conference Call Today at 2:00 PM Eastern Time

Sunesis Pharmaceuticals Reports Second Quarter 2017 Financial Results And Recent Highlights

Sunesis Pharmaceuticals Reports Second Quarter 2017 Financial Results And Recent Highlights

Sunesis to Host Conference Call Today at 2:00 PM Eastern Time

Sunesis Pharmaceuticals Reports First Quarter 2017 Financial Results And Recent Highlights

Sunesis to Host Conference Call Today at 2:00 PM Eastern Time